Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30
Published December 6, 2023 · Recall initiated: November 10, 2023
Summary
FDA records drug Class III recall D-0127-2024, published December 6, 2023 and initiated November 10, 2023. Recalling firm: Teva Pharmaceuticals USA, Inc; Status: Terminated; Lot: Lot #: 100029472, Exp. 2/29/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
OOS for viscosity
What to do
Voluntary: Firm initiated
Get an email if TESTOSTERONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TESTOSTERONE
- Manufacturer
- Teva Pharmaceuticals USA, Inc
- Distributor
- USA nationwide
- Lot
- Lot #: 100029472, Exp. 2/29/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarton label: Testosterone Gel 1%, 2.5 grams per unit dose, CIII, 30 unit-dose packets, Rx only, ManufacturedDecember 10, 2025
- FDATestosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides Pharma Inc.,April 2, 2025
- FDATestosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Distributed by: Strides PharmaApril 2, 2025
- FDATestosterone Gel, 1.62%, (Alcohol 80% v/v), 30 unit-dose packets, Rx Only, Teva Pharmaceuticals, USA, Inc.August 28, 2024
- FDAAminocaproic Acid Oral Solution, 0.25 grams/mL, Rx only, packaged in 8 Fl. Oz. (236.5 mL) HDPE bottles,December 6, 2023
- FDAPAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count bottle NDCDecember 6, 2023
Questions about this recall
Was Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30 recalled?
Yes. FDA published recall D-0127-2024 on December 6, 2023. Reported hazard: OOS for viscosity
What should I do if I have this product?
Voluntary: Firm initiated
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TESTOSTERONE.